IRadimed Corporation (IRMD)
NASDAQ: IRMD · IEX Real-Time Price · USD
41.47
-0.97 (-2.29%)
Apr 25, 2024, 4:00 PM EDT - Market closed
IRadimed Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for IRadimed stock has a target of 65, which predicts an increase of 56.74% from the current stock price of 41.47.
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for IRadimed is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Roth MKM | Roth MKM | Strong Buy Initiates $65 | Strong Buy | Initiates | $65 | +56.74% | Apr 22, 2024 |
Roth Capital | Roth Capital | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Aug 2, 2021 |
Roth Capital | Roth Capital | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Oct 31, 2017 |
Roth Capital | Roth Capital | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Jul 31, 2017 |
Financial Forecast
Revenue This Year
74.27M
from 65.56M
Increased by 13.28%
Revenue Next Year
81.70M
from 74.27M
Increased by 10.01%
EPS This Year
1.56
from 1.35
Increased by 15.60%
EPS Next Year
1.70
from 1.56
Increased by 9.15%
Revenue Forecast
Revenue | 2024 | 2025 |
---|---|---|
High | 77.8M | 84.1M |
Avg | 74.3M | 81.7M |
Low | 70.1M | 78.5M |
Revenue Growth
Revenue Growth | 2024 | 2025 |
---|---|---|
High | 18.7% | 13.2% |
Avg | 13.3% | 10.0% |
Low | 6.9% | 5.7% |
EPS Forecast
EPS | 2024 | 2025 |
---|---|---|
High | 1.62 | 1.75 |
Avg | 1.56 | 1.70 |
Low | 1.49 | 1.64 |
EPS Growth
EPS Growth | 2024 | 2025 |
---|---|---|
High | 19.8% | 12.4% |
Avg | 15.6% | 9.2% |
Low | 10.3% | 4.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.